The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Abstract
Many important decisions on hypertension management must currently be taken without the support of evidence \nfrom large randomized controlled trials. The following issues appear in urgent need to be approached by simply \ndesigned trials. \n(1) Should antihypertensive drugs be prescribed to all patients with grade 1 hypertension, even when total \ncardiovascular risk is relatively low or moderate? Because of the very low rate of cardiovascular events \nexpected in these patients, a placebo-controlled trial using intermediate endpoints such as signs of organ \ndamage of recognized prognostic importance would be feasible, ethical, and clinically relevant. \n(2) Should antihypertensive drugs be prescribed to the elderly with grade 1 hypertension, and should antihypertensive \ntreatment achieve a goal of below 140/90mmHg also in the elderly? These trials could make use \nof hard cardiovascular outcomes and could be placebo-controlled. \n(3) Should antihypertensive drug treatment be started in diabetic patients or in patients with previous cerebrovascular \nor cardiovascular disease when BP is still in the high normal level, and should BP goal be below 130/ \n80mmHg in these patients? These issues can be approached by placebo-controlled trials because no trial \nevidence is still available on the benefit of lowering high normal BP or of achieving BP goals below 130/ \n80mmHg. \n(4) What are the lowest safe BP values to achieve by treatment in different clinical conditions? This issue should \nbe approached by trials comparing more or less intense BP-lowering treatment strategies in patients with \ndifferent cardiovascular risk levels. \n(5) Are lifestyle measures known to reduce BP also capable of reducing morbidity and mortality in hypertension? \nA controlled randomized trial using intermediate endpoints (organ damage) would be feasible and desirable \nin patients with high normal BP or grade 1 hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–305 of 305
Staessen, J. A., Thijs, L., Fagard, R., Celis, H., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Fletcher, A. E., Forette, F., Leonetti, G., et al. (2004) · Journal of Hypertension · doi:10.1097/00004872-200404000-00029 · Cited by 188
Self-citationMathiassen, O. N., Buus, N. H., Sihm, I., Thybo, N. K., Mørn, B., Schroeder, A. P., Thygesen, K., Aalkjaer, C., Lederballe, O., Mulvany, M. J., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32805bf8ed · Cited by 188
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
Nasr, I. A., Bouzamondo, A., Hulot, J.-S., Dubourg, O., Le Heuzey, J.-Y., & Lechat, P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl484 · Cited by 188
on behalf of the AdRem* project team and ADVANCE management committee, Beulens, J. W. J., Patel, A., Vingerling, J. R., Cruickshank, J. K., Hughes, A. D., Stanton, A., Lu, J., McG Thom, S. A., Grobbee, D. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1457-x · Cited by 188
Differential Effects of Nifedipine and Co-Amilozide on the Progression of Early Carotid Wall Changes
Simon, A., Gariépy, J., Moyse, D., & Levenson, J. (2001) · Circulation · doi:10.1161/01.cir.103.24.2949 · Cited by 183
Bakris, G., Molitch, M., Hewkin, A., Kipnes, M., Sarafidis, P., Fakouhi, K., Bacher, P., Sowers, J., & on behalf of the STAR Investigators (2006) · Diabetes Care · doi:10.2337/dc06-1373 · Cited by 183
Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension
Mitchell, G. F., Conlin, P. R., Dunlap, M. E., Lacourcière, Y., Arnold, J. M. O., Ogilvie, R. I., Neutel, J., Izzo, J. L., & Pfeffer, M. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.099721 · Cited by 180
Mozaffarian, D., Marfisi, R., Levantesi, G., Silletta, M. G., Tavazzi, L., Tognoni, G., Valagussa, F., & Marchioli, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61343-9 · Cited by 179
Diabetic Nephropathy: Can Renoprotection Be Extrapolated to Cardiovascular Protection?
Opie, L. H., & Parving, H.-H. (2002) · Circulation · doi:10.1161/01.cir.0000028099.24188.c4 · Cited by 178
Left Ventricular Geometry and Survival in Patients With Normal Left Ventricular Ejection Fraction
Milani, R. V., Lavie, C. J., Mehra, M. R., Ventura, H. O., Kurtz, J. D., & Messerli, F. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.030 · Cited by 175
Cucherat, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm489 · Cited by 175
Torp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Remme, W. J., et al. (2007) · Heart · doi:10.1136/hrt.2006.092379 · Cited by 171
on behalf of the COLM study investigators, Ogihara, T., Saruta, T., Rakugi, H., Shimamoto, K., Ito, S., Matsuoka, H., Horiuchi, M., Imaizumi, T., Takishita, S., et al. (2009) · Hypertension Research · doi:10.1038/hr.2008.31 · Cited by 169
Burke, T. A., Sturkenboom, M. C., Lu, S.-E., Wentworth, C. E., Lin, Y., & Rhoads, G. G. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226211.95936.f5 · Cited by 167
Gerdts, E., Cramariuc, D., de Simone, G., Wachtell, K., Dahlof, B., & Devereux, R. B. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jen155 · Cited by 167
Bombelli, M., Facchetti, R., Carugo, S., Madotto, F., Arenare, F., Quarti-Trevano, F., Capra, A., Giannattasio, C., Dell'Oro, R., Grassi, G., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328330b845 · Cited by 166
Self-citationReboldi, G., Angeli, F., Cavallini, C., Gentile, G., Mancia, G., & Verdecchia, P. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328306ebe2 · Cited by 164
Self-citationSever, P., Dahlof, B., Poulter, N., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S., Kristinsson, A., McInnes, G., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl403 · Cited by 161
Self-citationHarazny, J. M., Ritt, M., Baleanu, D., Ott, C., Heckmann, J. G., Schlaich, M. P., Michelson, G., & Schmieder, R. E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.090779 · Cited by 161
Self-citationZanchetti, A., Crepaldi, G., Bond, M. G., Gallus, G., Veglia, F., Mancia, G., Ventura, A., Baggio, G., Sampieri, L., Rubba, P., et al. (2004) · Stroke · doi:10.1161/01.str.0000147041.00840.59 · Cited by 154
Self-citationZanchetti, A., Hennig, M., Hollweck, R., Bond, G., Tang, R., Cuspidi, C., Parati, G., Facchetti, R., & Mancia, G. (2009) · Circulation · doi:10.1161/circulationaha.108.773119 · Cited by 153
Self-citationSexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications
Manolis, A. J., & Doumas, M. N. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830dd0c6 · Cited by 147
Self-citationMesserli, F. H., Bangalore, S., & Julius, S. (2008) · Circulation · doi:10.1161/circulationaha.107.695007 · Cited by 147
Latin American guidelines on hypertension*
Sanchez, R. A., Ayala, M., Baglivo, H. P., Velazquez, C., Burlando, G., Kohlmann, O., Jimenez, J., López-Jaramillo, P. A., Brandao, A., Valdés, G., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832aa6d2 · Cited by 146
Self-citationDiabetes and Cardiovascular Events in Hypertensive Patients
Alderman, M. H., Cohen, H. W., & Madhavan, S. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1130 · Cited by 142
Ciuceis, C. D., PORTERI, E., Rizzoni, D., Rizzardi, N., Paiardi, S., Boari, G. E. M., Miclini, M., Zani, F., Muiesan, M. L., & Donato, F. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.016 · Cited by 137
Lubsen, J. C., Wagener, G., Kirwan, B., de Brouwer, S., & Poole-Wilson, P. A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160223.94220.29 · Cited by 132
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study
Bakris, G. L., Gaxiola, E., Messerli, F. H., Mancia, G., Erdine, S. E., Cooper‐DeHoff, R. M., & Pepine, C. J. (2004) · Hypertension · doi:10.1161/01.hyp.0000143851.23721.26 · Cited by 127
Self-citationAdditive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade
Ferrari, P., Marti, H., Pfister, M., & Frey, F. J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200201000-00018 · Cited by 123
Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?
Zanchetti, A. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832e9500 · Cited by 122
Self-citationBénétos, A., Thomas, F., Bean, K., & Guize, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00011 · Cited by 116
Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Middle-Aged and Elderly Japanese Men
Inoue, N., Maeda, R., Kawakami, H., Shokawa, T., Yamamoto, H., Ito, C., & Sasaki, H. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0492 · Cited by 114
Candesartan in the prevention of relapsing atrial fibrillation
Tveit, A., Grundvold, I., Olufsen, M., Seljeflot, I., Abdelnoor, M., Arnesen, H., & Smith, P. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.08.086 · Cited by 112
Metabolic Profile of Nebivolol, a ??-Adrenoceptor Antagonist with Unique Characteristics
Rosei, E. A., & Rizzoni, D. (2007) · Drugs · doi:10.2165/00003495-200767080-00001 · Cited by 110
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients
Costanzo, P., Filardi, P. P., Petretta, M., Marciano, C., Vassallo, E., Gargiulo, P., Paolillo, S., Petretta, A., & Chiariello, M. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283281254 · Cited by 109
Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity
Havranek, E. P., Froshaug, D. B., Emserman, C. D. B., Hanratty, R., Krantz, M. J., Masoudi, F. A., Dickinson, L. M., & Steiner, J. F. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.05.034 · Cited by 107
Ambrosioni, E., Leonetti, G., Pessina, A. C., RAPPELLI, A., Trimarco, B., & Zanchetti, A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018110-00023 · Cited by 107
Self-citationCírillo, M., Lanti, M. P., Menotti, A., Laurenzi, M., Mancini, M., Zanchetti, A., & Santo, N. G. D. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.617 · Cited by 107
Self-citationLithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000133730.47372.4c · Cited by 104
Self-citationParving, H., Hommel, E. E., Jensen, B. R., & Hansen, H. P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00790.x · Cited by 104
Clinical Significance of Renal Function in Hypertensive Patients at High Risk
de Leeuw, P. W., Ruilope, L. M., Palmer, C. R., Brown, M. J., Castaigne, A., Mancia, G., Rosenthal, T., & Wagener, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.22.2459 · Cited by 101
Self-citationEstacio, R., Coll, J. R., Tran, Z. V., & Schrier, R. W. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.05.011 · Cited by 99
Losartan and Prevention of Atrial Fibrillation Recurrence in Hypertensive Patients
Fogari, R., Mugellini, A., Destro, M., Corradi, L., Zoppi, A., Fogari, E., & Rinaldi, A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000193808.99773.28 · Cited by 99
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients
Muiesan, M. L., Salvetti, M., Paini, A., Monteduro, C., Galbassini, G., Poisa, P., Porteri, E., Agabiti-Rosei, C., Paderno, V., Belotti, E., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328304b083 · Cited by 96
Self-citationThe COOPERATE trial: a letter of concern
Kunz, R., Wolbers, M., Glass, T. R., & Mann, J. F. E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60681-9 · Cited by 94
Almgren, T., Persson, B., Wilhelmsen, L., Rosengren, A., & Andersson, O. K. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01497.x · Cited by 89
Albuminuria: A Target for Treatment of Type 2 Diabetic Nephropathy
de Zeeuw, D. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.002 · Cited by 89
Zanchetti, A., Hennig, M., Baurecht, H., Tang, R., Cuspidi, C., Carugo, S., & Mancia, G. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f063d5 · Cited by 88
Self-citationKaiser, T., Heise, T., Nosek, L., Eckers, U., & Sawicki, P. T. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000234121.48272.67 · Cited by 87
Zanchetti, A., Hansson, L., Dahlöf, B., Julius, S., Ménard, J., Warnold, I., & Wedel, H. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00031 · Cited by 86
Self-citationMechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 86
Self-citationSchiffrin, E. L., Pu, Q., & Park, J. B. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02290-7 · Cited by 85
Zanchetti, A. (2004) · Blood Pressure · doi:10.1080/08038020410016548 · Cited by 84
Self-citationMuiesan, M. L., Salvetti, M., Paini, A., Monteduro, C., Galbassini, G., Bonzi, B., Poisa, P., Belotti, E., Rosei, C. A., Rizzoni, D., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087320 · Cited by 84
Neurohumoral Effects of the New Orally Active Renin Inhibitor, Aliskiren, in Chronic Heart Failure
Seed, A., Gardner, R. S., McMurray, J. J. V., Hillier, C., Murdoch, D., MacFadyen, R. J., Bobillier, A., Mann, J., & McDonagh, T. A. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.002 · Cited by 83
(2007) · Diabetes Care · doi:10.2337/dc07-er05 · Cited by 82
Ichihara, A., Kaneshiro, Y., Takemitsu, T. Y., & Sakoda, M. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002067 · Cited by 80
High Risk of Cerebro‐cardiovascular Morbidity in Well Treated Male Hypertensives
Lindholm, L. H., Ejlertsson, G., & Scherstén, B. (1984) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1984.tb03802.x · Cited by 78
Therapeutic Potential of Renin Inhibitors in the Management of Cardiovascular Disorders
Stanton, A. V. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303060-00002 · Cited by 78
Ruilope, L. M., Zanchetti, A., Julius, S., McInnes, G. T., Segura, J., Stolt, P., Hua, T. A., Weber, M. A., & Jamerson, K. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328133246c · Cited by 74
Self-citationBerthet, K., Neal, B. C., Chalmers, J. P., MacMahon, S. W., Bousser, M., Colman, S., Woodward, M., & on behalf of the PROGRESS collaborative group (2004) · Blood Pressure · doi:10.1080/08037050410029605 · Cited by 71
Asayama, K., Ohkubo, T., Yoshida, S., Suzuki, K., Metoki, H., Harada, A., Murakami, Y., Ohashi, Y., Ueshima, H., & Imai, Y. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831967ca · Cited by 69
Tsioufis, C. P., Vezali, E., Tsiachris, D., Dimitriadis, K. S., Taxiarchou, E., Chatzis, D., Thomopoulos, C., Syrseloudis, D., Stefanadi, E., Mihas, C. C., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832401ff · Cited by 68
Littlejohn, T. W., Trenkwalder, P., Hollanders, G., Zhao, Y., & Liao, W. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902785845 · Cited by 66
Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients
Henskens, L. H. G., van Oostenbrugge, R. J., Kroon, A. A., Hofman, P. A. M., Lodder, J., & de Leeuw, P. W. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283232c96 · Cited by 65
Amar, J., Vaur, L., Perret, M., Bailleau, C., Etienne, S., & Chamontin, B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200204000-00038 · Cited by 65
Zanchetti, A., Mancia, G., Black, H. R., Oparil, S., Waeber, B., Schmieder, R. E., Bakris, G. L., Messerli, F. H., Kjeldsen, S. E., & Ruilope, L. M. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283298ea2 · Cited by 63
Self-citationMancia, G., Bombelli, M., Facchetti, R., Madotto, F., Corrao, G., Trevano, F. Q., Giannattasio, C., Grassi, G. M., & Sega, R. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328302f10d · Cited by 63
Self-citationNorton, G. R., Maseko, M. J., Libhaber, E. N., Libhaber, C. D., Majane, O. H. I., Dessein, P. H., Sareli, P., & Woodiwiss, A. J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328311f296 · Cited by 63
Smith, R. D., Yokoyama, H., Averill, D. B., Schiffrin, E. L., & Ferrario, C. M. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2007.11.001 · Cited by 58
Dart, A. M., Cameron, J. D., Gatzka, C. D., Willson, K. J., Liang, Y., Berry, K. L., Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.085803 · Cited by 58
Verdecchia, P., Angeli, F., Cavallini, C., Mazzotta, G., Repaci, S., Pede, S., Borgioni, C., Gentile, G., & Reboldi, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832c0031 · Cited by 53
Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension
Cutler, J. A., & Davis, B. R. (2008) · Circulation · doi:10.1161/circulationaha.107.709931 · Cited by 51
Taylor, H. A., Penman, A. D., Han, H., Dele-Michael, A., Skelton, T. N., Fox, E. R., Benjamin, E. J., Arnett, D. K., & Mosley, T. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.12.065 · Cited by 50
Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
Sehestedt, T. B., Jeppesen, J., Hansen, T. W., Rasmussen, S. L., Wachtell, K., Ibsen, H., Torp-Pedersen, C. T., & Olsen, M. H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832af343 · Cited by 47
Self-citationEffect of Treating Erectile Dysfunction on Management of Systolic Hypertension
Scranton, R. E., Lawler, E. V., Botteman, M. F., Chittamooru, S., GAGNON, D. R., Lew, R., Harnett, J., & Gaziano, J. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.045 · Cited by 46
Mancia, G., & Zanchetti, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f52fa8 · Cited by 44
Self-citationBoutitie, F., Oprisiu, R., Achard, J. M., Mazouz, H., Wang, J., Messerli, F. H., Gueyffier, F., & Fournier, A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32814a5ae5 · Cited by 43
Thelle, D. S. (1995) · Journal of Hypertension · doi:10.1097/00004872-199505000-00014 · Cited by 41
Management of Hypertension in Peripheral Arterial Disease
Buyzere, M. L. D., & Clement, D. L. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.08.001 · Cited by 41
Sever, P., Poulter, N. R., Dahlöf, B., & Wedel, H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328326cb1a · Cited by 40
Houghton, T., Freemantle, N., & Cleland, J. G. F. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00100-8 · Cited by 40
Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents
Blackburn, D. F., Lamb, D. A., Eurich, D. T., Johnson, J. A., Wilson, T. W., Dobson, R. T., & Blackburn, J. L. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328136bd21 · Cited by 39
(2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.11.027 · Cited by 39
Effects of age on the cardiac and vascular limbs of the arterial baroreflex
Brown, C., Hecht, M. J., Weih, A., Neundörfer, B., & Hilz, M. J. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01093.x · Cited by 38
Yasuno, S., Ueshima, K., Oba, K., Fujimoto, A., Ogihara, T., Saruta, T., & Nakao, K. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832c6968 · Cited by 36
Volpe, M., Tocci, G., Sciarretta, S., Verdecchia, P., Trimarco, B., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832961ed · Cited by 34
Self-citationGalderisi, M., D’Errico, A., Sidiropulos, M., Innelli, P., DIVITIIS, O. D., & SIMONE, G. D. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832ea925 · Cited by 32
Li, Z., Dahlöf, B., Okin, P. M., Kjeldsen, S. E., Wachtell, K., Ibsen, H., Nieminen, M. S., Jern, S., & Devereux, R. B. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fcc23c · Cited by 29
Self-citationKaneshiro, Y., Ichihara, A., Sakoda, M., Kurauchi‐Mito, A., Kinouchi, K., & Itoh, H. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000205521 · Cited by 27
Rizzoni, D., Porteri, E., Ciuceis, C. D., Boari, G. E. M., Zani, F., Miclini, M., Paiardi, S., Tiberio, G. A., Giulini, S. M., Muiesan, M. L., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222756.76982.53 · Cited by 26
Management of antihypertensive drugs in three European countries
Nicotra, F., Wettermark, B., Sturkenboom, M., Parodi, A. F., Bellocco, R., Ekbom, A., Merlino, L. G., Leimanis, A., Mancia, G., Fored, M., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d4692 · Cited by 24
Self-citationTarget organ damage: how to detect it and how to treat it?
Waeber, B., de la Sierra, A., & Ruilope, L. M. (2009) · Journal of Hypertension · doi:10.1097/01.hjh.0000356767.24507.8d · Cited by 21
Self-citationOlmesartan Medoxomil/Amlodipine
Sanford, M., & Keam, S. J. (2009) · Drugs · doi:10.2165/00003495-200969060-00005 · Cited by 21
Single-pill combination of amlodipine and valsartan in the management of hypertension
Flack, J. M., & Hilkert, R. J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903120899 · Cited by 19
Cardio–renal organ damage and cardiovascular outcomes in hypertension
Cuspidi, C. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283295dbf · Cited by 17
Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes
Zanchetti, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_19 · Cited by 14
Self-citationIbsen, H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e9962 · Cited by 14
Beta-blockade should not be among several choices for initial therapy of hypertension
Opie, L. H. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f300a7 · Cited by 13
Prevention of risk factors: beta-blockade and hypertension
Mancia, G. (2009) · European Heart Journal Supplements · doi:10.1093/eurheartj/sup003 · Cited by 11
Self-citationRedón, J., Sleight, P., Mancia, G., Gao, P., Verdecchia, P., Fagard, R. H., Schumacher, H., Weber, M., Böehm, M., Williams, B., et al. (2009) · UCL Discovery (University College London) · Cited by 11
Self-citationVogt, L., Laverman, G. D., de Zeeuw, D., & Navis, G. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12803-6 · Cited by 10
Benefits and safety of long-acting calcium antagonists in coronary artery disease: the Action Trial
Fagard, R. H. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160202.35910.d6 · Cited by 8
Self-citationThe Development of Heart Failure in Patients with Stable Angina Pectoris
Sutton, G. C., Otterstad, J. E., Kirwan, B., Vokó, Z., de Brouwer, S., Lubsen, J. C., Poole-Wilson, P. A., & ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.09.002 · Cited by 4
Yao, S., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.011 · Cited by 3
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citation(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Self-citationLv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777
Metadata
- Authors
- Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., Erdine, S., Fagard, R., Farsang, C., Grassi, G., Haller, H., Heagerty, A., Kjeldsen, S. E., Kiowski, W., Mallion, J. M., Manolis, A., Narkiewicz, K., Nilsson, P., Olsen, M. H., Rahn, K. H., Redon, J., Rodicio, J., Ruilope, L., Schmieder, R. E., Struijker-Boudier, H. A. J., Van Zwieten, P. A., Viigimaa, M., & Zanchetti, A.
- Venue
- Blood Pressure
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 18
- Issue
- 6
- Pages
- 308-347
- ISSN
- 0803-7051 (ISSN-L)
- 1651-1999
- OpenAlex
- W1988716175
- Cited by
- 894
- References
- 305
- FWCI
- 88.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.